Patents by Inventor Alexander Christiaan SCHULTINK

Alexander Christiaan SCHULTINK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11891612
    Abstract: Provided herein is a plant comprising an exogenous polynucleotide encoding a JIM2 polypeptide. In some embodiments, the plants have enhanced resistance to at least one species of Xanthomonas.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: February 6, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Brian J. Staskawicz, Alexander Christiaan Schultink
  • Publication number: 20230257764
    Abstract: The present disclosure provides an isolated, recombinant, or synthetic polynucleotide comprising a FIT1 protein, and homologs, fragments, and variations thereof. The disclosure further relates to transgenic plants, plant parts, and plant cells comprising one or more of these polynucleotides, and exhibit resistance or tolerance to a pathogen, such as Phakopsora pachyrhizi. The disclosure further relates to methods of genetically engineering a pathogen resistance or tolerance trait in a plant, plant part, or plant cell, comprising targeted gene editing of a FIT1 homolog, and plants produced therefrom. The disclosure further relates to methods for identifying new functional FIT1 genes and/or alleles thereof.
    Type: Application
    Filed: December 6, 2022
    Publication date: August 17, 2023
    Applicant: Fortiphyte, Inc.
    Inventors: Alexander Christiaan SCHULTINK, Laura A. WETZEL
  • Patent number: 11530419
    Abstract: The present disclosure provides an isolated, recombinant, or synthetic polynucleotide comprising a FIT1 protein, and homologs, fragments, and variations thereof. The disclosure further relates to transgenic plants, plant parts, and plant cells comprising one or more of these polynucleotides, and exhibit resistance or tolerance to a pathogen, such as Phakopsora pachyrhizi. The disclosure further relates to methods of genetically engineering a pathogen resistance or tolerance trait in a plant, plant part, or plant cell, comprising targeted gene editing of a FIT1 homolog, and plants produced therefrom. The disclosure further relates to methods for identifying new functional FIT1 genes and/or alleles thereof.
    Type: Grant
    Filed: October 27, 2021
    Date of Patent: December 20, 2022
    Assignee: Fortiphyte, Inc.
    Inventors: Alexander Christiaan Schultink, Laura A. Wetzel
  • Publication number: 20220135997
    Abstract: The present disclosure provides an isolated, recombinant, or synthetic polynucleotide comprising a FIT1 protein, and homologs, fragments, and variations thereof. The disclosure further relates to transgenic plants, plant parts, and plant cells comprising one or more of these polynucleotides, and exhibit resistance or tolerance to a pathogen, such as Phakopsora pachyrhizi. The disclosure further relates to methods of genetically engineering a pathogen resistance or tolerance trait in a plant, plant part, or plant cell, comprising targeted gene editing of a FIT1 homolog, and plants produced therefrom. The disclosure further relates to methods for identifying new functional FIT1 genes and/or alleles thereof.
    Type: Application
    Filed: October 27, 2021
    Publication date: May 5, 2022
    Inventors: Alexander Christiaan SCHULTINK, Laura A. WETZEL
  • Patent number: 11236355
    Abstract: Provided herein is a non-Nicotiana transgenic plant comprising an exogenous polynucleotide encoding Nicotiana benthamiana Roq1 or a variant thereof. These plants have enhanced resistance to at least one species of Xanthomonas, Pseudomonas, Ralstonia, and/or another pathogen containing a homolog of XopQ whose recognition is mediated by Roq1.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: February 1, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Brian J. Staskawicz, Alexander Christiaan Schultink
  • Publication number: 20210310019
    Abstract: Provided herein is a plant comprising an exogenous polynucleotide encoding a JIM2 polypeptide. In some embodiments, the plants have enhanced resistance to at least one species of Xanthomonas.
    Type: Application
    Filed: May 24, 2019
    Publication date: October 7, 2021
    Inventors: Brian J. STASKAWICZ, Alexander Christiaan SCHULTINK
  • Publication number: 20210130843
    Abstract: Provided herein is a non-Nicotiana transgenic plant comprising an exogenous polynucleotide encoding Nicotiana benthamiana Roq1 or a variant thereof. These plants have enhanced resistance to at least one species of Xanthomonas, Pseudomonas, Ralstonia, and/or another pathogen containing a homolog of XopQ whose recognition is mediated by Roq1.
    Type: Application
    Filed: August 21, 2018
    Publication date: May 6, 2021
    Inventors: Brian J. STASKAWICZ, Alexander Christiaan SCHULTINK